Contacts
Russia, Moscow,
129090
Prospekt Mira, 13 bldg. 1
+7 (495) 640-25-28
reception@promomed.pro
Hot line
Close
Menu
Home page
Company
Contacts
News
Drug products
For investors
Disclosure of information on PROMOMED DM LLC
Disclosure of information on PROMOMED JSC
Research
For partners
Сareer
Pharmacovigilance
Map of site
© Promomed. 2023
Personal data processing policy
For investors
Disclosure of information on Promomed DM LLC
Disclosure of information on Promomed JSC
CN
RU
Menu
“Biopharmaceutical medicines are in great demand, and Russia could provide them not only to domestic market, but also export to other countries”
Vladimir Putin took part in the launch of production at JSC «Biochemist»
RSPP gave an assessment to Promomed Group
Promomed launches the innovative import-substituting drug product Enligria for the treatment of overweight and obesity
Main
Company
News
Drug products
For investors
Pharmacovigilance
Company
News
Drug products
For investors
Pharmacovigilance
Company
Watch
Video 0:18
More than 80%
of drug products are in the
EDL list *
82.4
%
*Essential Drugs List
News
Mass media
1
December
Promomed Group wins two awards of IP RUSSIA AWARDS 2023
Promomed
24
November
The Plenipotentiary Representative of the President of the Russian Federation in the Volga Federal District Igor Komarov was informed about import substitution projects of Promomed Group
Promomed
17
November
Expert RA confirms the long-term credit rating of Promomed DM at ruA- level with stable outlook
Promomed
For investors
Information disclosure
Drugs
Pharmacovigilance
